Stock Price Quote

PARENTERAL DRUGS (INDIA) LTD.

NSE : PDPLBSE : 524689ISIN CODE : INE904D01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.620 (0 %)
PREV CLOSE ( ) 3.62
OPEN PRICE ( ) 3.98
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2970
TODAY'S LOW / HIGH ( )3.62 3.99
52 WK LOW / HIGH ( )2.51 5.87
NSE3.200 (0 %)
PREV CLOSE( ) 3.20
OPEN PRICE ( ) 3.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 200
TODAY'S LOW / HIGH( ) 3.20 3.20
52 WK LOW / HIGH ( )2.5 4.45
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1983
Management Info
Manohar Lal Gupta - Chairman Vinod Kumar Gupta - Managing Director
Registered Office

Address 340, Laxmi Plaza,Laxmi Industrial Estate ,New Link Road, Andheri ( West ),
Mumbai,
Maharashtra-400053

Phone 022-61725900

Email pdpl@pdindia.com

Website www.pdindia.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

25Aug Announcement Under Regulation 30 (LOD
Parenteral Drugs (India) Limited hereby submits intimation under Regulat..
24Apr Parenteral Drugs (India) informs about
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Reg..
24Apr Parenteral Drugs (India) informs about
Parenteral Drugs (India) has informed that it has enclosed the Complianc..
15Feb Parenteral Drugs (India) submits clipp
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
12Feb Parenteral Drugs informs about unaudit
Pursant to the provisions of Regulation 33 of the SEBI (Listing Obligati..

Financials

in Millions
QTR Mar 22 ANNUAL 22
Net Profit238.14-763.61
Gross Profit 192.11 -1091.25
Operating Profit -58.46-149.41
Net Sales 18.1385.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  3108.30 (3.58%)
M.Cap ( in Cr)7770.75
Procter&Gamble Healt (BSE)
peergroup  4090.40 (2.11%)
M.Cap ( in Cr)6789.81
RPG Life Sciences (BSE)
peergroup  807.80 (10.83%)
M.Cap ( in Cr)1336.02
Neuland Laboratories (BSE)
peergroup  1362.85 (5.36%)
M.Cap ( in Cr)1748.52
Medicamen Biotech (BSE)
peergroup  1025.50 (3.56%)
M.Cap ( in Cr)1297.37

Shareholding Pattern

PROMOTERS 73.29%
NON-INSTITUTION 26.71%
MUTUAL FUNDS/UTI 0.01%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
DSP Midcap Fund-Reg(G)0.57

About Parenteral Drugs (India) Ltd.

Parenteral Drugs (India) Ltd. was incorporated in the year 1983. Its today's share price is 3.62. Its current market capitalisation stands at Rs 9.54 Cr. In the latest quarter, company has reported Gross Sales of Rs. 121.68 Cr and Total Income of Rs.122.31 Cr. The company's management includes Chhaya Gupta, Manish Verma, Dilip Kumar Sinha, Dharam Pal Khanna, Anil Mittal, Manohar Lal Gupta, Govind Das Garg, Vinod Kumar Gupta.

It is listed on the BSE with a BSE Code of 524689 , NSE with an NSE Symbol of PDPL and ISIN of INE904D01019. It's Registered office is at 340, Laxmi Plaza,Laxmi Industrial Estate ,New Link Road, Andheri ( West )Mumbai-400053, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Singhal Jain & Co, TN Unni & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)